CA
APTO

Corriente Advisors’s Aptose Biosciences, Inc. APTO Stock Holding History

Corriente Advisors’s Portfolio APTO Stock Details APTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-6,444
Closed -$12.7M – 21
2020
Q4 		$12.7M Sell
6,444
-1,178
-15% -$2.77M 3.02% 10
2020
Q3 		$20.6M Buy
7,622
+1,464
+24% +$3.65M 10.44% 4
2020
Q2 		$17.5M Sell
6,158
-326
-5% -$1.05M 11.33% 4
2020
Q1 		$17.3M Buy
6,484
+5,477
+544% +$16.3M 18.71% 3
2019
Q4 		$2.57M Buy
+1,007
New +$1.31M 1.38% 12

Other funds holding APTO

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Corriente Advisors's APTO Position: Q1 2021 in Review

Corriente Advisors sold out of Aptose Biosciences, Inc. (APTO) in Q1 2021, closing a stake of 6,444 shares — an estimated $12.7M sold.

Corriente Advisors first reported a position in APTO in Q4 2019 and held it in 5 quarters. The position peaked at $20.6M in Q3 2020. 70 funds tracked by Wall St. Rank hold APTO as of Q1 2021.

  • Corriente Advisors reported no remaining Aptose Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Corriente Advisors sold 6,444 Aptose Biosciences, Inc. shares in Q1 2021, an estimated $12.7M.
  • Corriente Advisors first reported a position in Aptose Biosciences, Inc. in Q4 2019 and held it in 5 quarters.
  • Corriente Advisors's Aptose Biosciences, Inc. position peaked at $20.6M in Q3 2020.
  • 70 funds tracked by Wall St. Rank held Aptose Biosciences, Inc. as of Q1 2021.

Based on Corriente Advisors's 13F filing for Q1 2021, filed 18 May 2021.